LE Ronnblom, GV Alm, KE Oberg - Annals of internal medicine, 1991 - Am Coll Physicians Objective: To determine the incidence of autoantibodies and autoimmune disease
and their influence on therapeutic results during alpha-interferon treatment in
patients with malignant midgut carcinoid tumors. ... Patients: One hundred ... Cited by 264 - Related articles - All 3 versions
LE Ronnblom, GV Alm, KE Oberg… - J Intern Med, 1990 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 159 - Related articles - All 3 versions
- ►umich.edu [PDF] SR Ytterberg, TJ Schnitzer - Arthritis & Rheumatism, 1982 - deepblue.lib.umich.edu Levels of interferon (IFN) were measured in 81 ... From the Rackham Arthritis
Research Unit, University of Michigan Medical School, Ann Arbor, MI 48109.
Supported in part by US Public Health Service Training Grant #ST32 ... Cited by 170 - Related articles - View as HTML - All 3 versions
PIA Burman, TH TOTTERMAN, K Oberg, FA … - Journal of Clinical Endocrinology & Metabolism, 1986 - Endocrine Soc During treatment, an increase in the proportions of circulating activated
surface HLA-DR-positive T-helper and T-suppressor cells occurred after 3-4 days,
and the proportions remained elevated at 3 and 6 months. Incubation of T ... Cited by 173 - Related articles - All 3 versions
- ►oxfordjournals.org [PDF] KM Kalkner, L Ronnblom, AK Karlsson Parra, … - Qjm, 1998 - Oxford Univ Press Page 1. QJ Med 1998; 91:393–399 Original papers QJM Antibodies against double-stranded
DNA and development of polymyositis during treatment with interferon ... Cited by 70 - Related articles - BL Direct - All 5 versions
Y Ioannou, DA Isenberg - Arthritis & Rheumatism, 2000 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 141 - Related articles - BL Direct - All 3 versions
- ►nih.gov [PDF] H Gisslinger, B Gilly, W Woloszczuk, WR Mayr … - Clinical and Experimental Immunology, 1992 - pubmedcentral.nih.gov SUMMARY Forty-five patients with myeloproliferative or myelodysplastic
syndromes, treated with recombinant interferon-alpha (rIFN-o) for a minimum of 1
up to 4 years, were examined for the occurrence of thyroid autoimmunity. ... Cited by 97 - Related articles - BL Direct - All 4 versions
H Vallin, S Blomberg, GV Alm, B Cederblad, … - Clinical and Experimental Immunology, 1999 - pubmedcentral.nih.gov Patients with active SLE often have an ongoing production of IFN-α. We
therefore searched for an endogenous IFN-α-inducing factor (IIF) in SLE
patients and found that their sera frequently induced production of IFN-α ... Cited by 122 - Related articles - All 3 versions
B Cederblad, S Blomberg, H Vallin, A Perers, … - Journal of Autoimmunity, 1998 - Elsevier Systemic lupus erythematosus (SLE) patients often have continuous production of
interferon-α (IFN-α), but production of in vitro IFN-α by peripheral blood
mononuclear cells (PBMC) may be varyingly reduced. We here report that ... Cited by 117 - Related articles - BL Direct - All 5 versions
KC Conlon, WJ Urba, JW Smith - CA A Cancer Journal for Clinicians - interscience.wiley.com The occurrence of autoimmune disease in patients receiving alpha-interferon (
:-IFN) therapy has been reported in several studies; these include autoimmune
thyroiditis, thrombocytopenia, anemia, exacerbation of psoriasis, and the ... Cited by 201 - Related articles - All 2 versions
